Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PICTON PROPERTY INCOME LTD. We currently have 2 research reports from 2 professional analysts.
|13Feb17 16:48||PRN||Holding(s) in Company|
|13Feb17 07:00||PRN||Non-Core Asset Disposal|
|10Feb17 13:43||PRN||Holding(s) in Company|
|10Feb17 13:31||PRN||Director/PDMR Shareholding|
|03Feb17 13:57||PRN||Holding(s) in Company|
|01Feb17 15:02||PRN||Grant of Awards Under Long Term Incentive Plan|
|24Jan17 07:00||PRN||Net Asset Value and Interim Dividend|
Frequency of research reports
Research reports on
PICTON PROPERTY INCOME LTD
PICTON PROPERTY INCOME LTD
Listed Real Estate
20 May 16
There are suggestions that the sector has peaked, but we feel this relates more to Central London than the rest of the country: the EU referendum has certainly provided an excuse to ‘wait and see’, compounding the effect of any uncertainty. Activity levels have suffered and the growth momentum slowed, and this is now showing up clearly in market data. However, the impact is not universal and is concentrated on the more exposed investment areas of Central London, leaving bright spots across the sector for investors to exploit.
More of the same
08 Apr 15
Q1 2015 saw c£1.8bn raised of which £1.2bn came from IPOs and selected secondary issues (see table). Despite widening discounts in the equity income sector, yielding alternative assets continued to dominate. Primary and secondary issues were well spread within the alternatives space but Gabelli’s (GVP) £100m (target £250m) IPO suggests it remains tricky to slot equity portfolios into a closed-end structure. All three IPOs came with a large minority shareholder (the manager in GVP’s case). Some secondary issues have seen funds achieve meaningful scale, lowering costs and enhancing the potential returns.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.